These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2). Zhong M; Lynch A; Muellers SN; Jehle S; Luo L; Hall DR; Iwase R; Carolan JP; Egbert M; Wakefield A; Streu K; Harvey CM; Ortet PC; Kozakov D; Vajda S; Allen KN; Whitty A Biochemistry; 2020 Feb; 59(4):563-581. PubMed ID: 31851823 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning. Shimizu Y; Yonezawa T; Sakamoto J; Furuya T; Osawa M; Ikeda K Sci Rep; 2021 Apr; 11(1):7420. PubMed ID: 33795749 [TBL] [Abstract][Full Text] [Related]
6. Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery. Narayanan D; Tran KT; Pallesen JS; Solbak SMØ; Qin Y; Mukminova E; Luchini M; Vasilyeva KO; González Chichón D; Goutsiou G; Poulsen C; Haapanen N; Popowicz GM; Sattler M; Olagnier D; Gajhede M; Bach A J Med Chem; 2022 Nov; 65(21):14481-14526. PubMed ID: 36263945 [TBL] [Abstract][Full Text] [Related]
7. A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity. Tran KT; Pallesen JS; Solbak SMØ; Narayanan D; Baig A; Zang J; Aguayo-Orozco A; Carmona RMC; Garcia AD; Bach A J Med Chem; 2019 Sep; 62(17):8028-8052. PubMed ID: 31411465 [TBL] [Abstract][Full Text] [Related]
8. Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases. Pallesen JS; Tran KT; Bach A J Med Chem; 2018 Sep; 61(18):8088-8103. PubMed ID: 29750408 [TBL] [Abstract][Full Text] [Related]
9. Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions. Jiang ZY; Lu MC; You QD J Med Chem; 2016 Dec; 59(24):10837-10858. PubMed ID: 27690435 [TBL] [Abstract][Full Text] [Related]
10. Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability. Lazzara PR; David BP; Ankireddy A; Richardson BG; Dye K; Ratia KM; Reddy SP; Moore TW J Med Chem; 2020 Jun; 63(12):6547-6560. PubMed ID: 31682434 [TBL] [Abstract][Full Text] [Related]
11. Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein-Protein Interaction. Zhang Y; Shi Z; Zhou Y; Xiao Q; Wang H; Peng Y J Med Chem; 2020 Aug; 63(15):7986-8002. PubMed ID: 32233486 [TBL] [Abstract][Full Text] [Related]
12. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery. Davies TG; Wixted WE; Coyle JE; Griffiths-Jones C; Hearn K; McMenamin R; Norton D; Rich SJ; Richardson C; Saxty G; Willems HM; Woolford AJ; Cottom JE; Kou JP; Yonchuk JG; Feldser HG; Sanchez Y; Foley JP; Bolognese BJ; Logan G; Podolin PL; Yan H; Callahan JF; Heightman TD; Kerns JK J Med Chem; 2016 Apr; 59(8):3991-4006. PubMed ID: 27031670 [TBL] [Abstract][Full Text] [Related]
13. Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding. Huerta C; Jiang X; Trevino I; Bender CF; Ferguson DA; Probst B; Swinger KK; Stoll VS; Thomas PJ; Dulubova I; Visnick M; Wigley WC Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2537-2552. PubMed ID: 27474998 [TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions. Lu MC; Shao HL; Liu T; You QD; Jiang ZY Eur J Med Chem; 2020 Dec; 207():112734. PubMed ID: 32866756 [TBL] [Abstract][Full Text] [Related]
15. Development of a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for the Inhibition of Keap1-Nrf2 Protein-Protein Interaction. Lee S; Abed DA; Beamer LJ; Hu L SLAS Discov; 2021 Jan; 26(1):100-112. PubMed ID: 32564647 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Structure-Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitors. Zhou HS; Hu LB; Zhang H; Shan WX; Wang Y; Li X; Liu T; Zhao J; You QD; Jiang ZY J Med Chem; 2020 Oct; 63(19):11149-11168. PubMed ID: 32902980 [TBL] [Abstract][Full Text] [Related]
17. Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction. Abed DA; Lee S; Hu L Bioorg Med Chem; 2020 Mar; 28(6):115343. PubMed ID: 32046917 [TBL] [Abstract][Full Text] [Related]